Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Related Donor Peripheral Stem Cells

NCT02356653 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT02356653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02356653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Related Donor Peripheral Stem Cells
Lead sponsor
Children's Hospital of Philadelphia
Phase
Phase 1
Overall status
Recruiting
Start date
December 31, 2013
Completion date
January 31, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow failure syndromes, immunodeficiencies, immunodysregulation polyendocrinopathy enteropathy x-linked syndrome, inborn errors of metabolism, leukemia